Valuation: Sysmex Corporation

Market Cap 915B 5.59B 4.91B 4.56B 4.2B 7.87B 541B 8.01B 54.57B 21.28B 264B 20.97B 20.51B P/E 2027 *
22.9x
P/E 2028 * 18.5x
Enterprise Value 934B 5.7B 5.01B 4.66B 4.28B 8.03B 552B 8.17B 55.67B 21.71B 269B 21.39B 20.93B EV / Sales 2027 *
1.74x
EV / Sales 2028 * 1.64x
Free-Float
72.3%
Yield 2027 *
2.55%
Yield 2028 * 2.67%
1 day+1.26%
1 week-6.02%
Current month+4.05%
1 month+12.01%
3 months+9.60%
6 months+0.76%
Current year-0.81%
1 week 1,494
Extreme 1494
1,646
1 month 1,358.5
Extreme 1358.5
1,646
Current year 1,246
Extreme 1246
1,646
1 year 1,246
Extreme 1246
2,539
3 years 1,246
Extreme 1246
3,243
5 years 1,246
Extreme 1246
5,241.67
10 years 1,246
Extreme 1246
5,241.67
Manager TitleAgeSince
Chief Executive Officer 76 01/04/2018
Director of Finance/CFO 56 -
President 65 01/04/2026
Director TitleAgeSince
Chairman 76 01/04/2013
Director/Board Member 65 01/06/2019
Director/Board Member 71 01/06/2019
Change 5-day change 1-year change 3-year change Capi.($)
+1.26%-6.02%-40.08%-52.20% 5.59B
+0.18%+1.94%-19.93%-11.85% 175B
+0.15%-1.85%-10.87%-7.81% 105B
+1.49%-0.95%+3.96%+58.40% 59.35B
-1.13%-2.60%+26.37%+54.76% 50.71B
-0.12%-4.35%-16.22%-42.24% 42.15B
+1.21%-8.47% - - 31.82B
-1.33%-9.62%-18.45%-46.03% 27.2B
-0.82%-1.92%+56.39%-5.79% 25.11B
+0.03%-4.74%-6.58%-9.24% 20.53B
Average +0.11%-3.34%-2.82%-6.89% 54.29B
Weighted average by Cap. +0.18%-1.52%-6.25%-0.62%

Financials

2027 *2028 *
Net sales 535B 3.27B 2.87B 2.67B 2.45B 4.6B 316B 4.68B 31.9B 12.44B 154B 12.26B 11.99B 567B 3.46B 3.04B 2.83B 2.6B 4.87B 335B 4.96B 33.78B 13.18B 163B 12.98B 12.7B
Net income 41.22B 252M 221M 205M 189M 354M 24.36B 361M 2.46B 958M 11.88B 944M 924M 49.94B 305M 268M 249M 229M 429M 29.51B 437M 2.98B 1.16B 14.4B 1.14B 1.12B
Net Debt 18.45B 113M 98.99M 91.97M 84.58M 159M 10.9B 161M 1.1B 429M 5.32B 423M 413M 16.07B 98.08M 86.26M 80.14M 73.7M 138M 9.5B 141M 958M 374M 4.63B 368M 360M
Logo Sysmex Corporation
Sysmex Corp is a Japan-based company principally engaged in the health care business. The Company conducts product development, manufacturing, sales, and service in domestic markets, and some products are developed, manufactured, and sold by subsidiaries. Overseas, the Company conducts the manufacturing and sales of products in the Americas, EMEA, China, and Asia Pacific through other companies. Along with its subsidiaries, the Company is involved in the development, manufacture, sale and service of clinical laboratory equipment, laboratory test drugs and products related to laboratory test.
Employees
10,861
Date Price Change Volume
24/07/26 JP¥1,530.00 +1.26% 1,663,800
23/07/26 JP¥1,511.00 -2.45% 2,238,000
22/07/26 JP¥1,549.00 -3.31% 2,539,000
21/07/26 JP¥1,602.00 -1.60% 3,166,200
17/07/26 JP¥1,628.00 +4.96% 5,271,100
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
1,511.00JPY
Average target price
1,738.57JPY
Spread / Average Target
+15.06%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 6869 Stock